Manhattan Scientifics Inc (MHTX)

[jim30jen]

The company's success is dependent on management's transition from "Revenue in exchange for shares" to "On going revenues from operations". In this case "operations" means license agreements and royalties. Though some of this is in place with CRS, there is much more to be done. It doesn't matter how good the technology is. Until the management proves it can make the transition and wean itself from the dilution teat, this penny stock will continue to be a crap shoot.